Clinical Assistant Professor
Research Interests:

–        Systemic Autoimmune Rheumatic Diseases (SARDs)

–        Systemic Lupus Erythematosus (SLE)

–        Rheumatoid Arthritis (RA)

–        Long term effectiveness

–        Multivariate analyses

–        Outcomes assessment

–        Pharmaco-epidemiology

MD, Universidad de Guadalajara, Guadalajara, Jalisco Mexico, Faculty of Medicine
MSc, University of Alberta, Edmonton AB, Experimental Medicine – Clinical Epidemiology
PhD, University of British Columbia, Vancouver BC, Experimental Medicine/Epidemiology
Arthritis Research Canada, Research Scientist
Vancouver Hospital and Health Sciences Centre, Active Staff, Rheumatology
St. Paul’s Hospital, Active Staff, Rheumatology
UBC, Assistant Professor, Department of Medicine
Recent Publications:
  1. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis. A meta-analysis of observational studies. Arthritis Rheum 2008;59:1690-1697.
  2. Goligher E, Pouchot J, Brandr R, Kherani R, Aviña-Zubieta JA, et al. The minimal clinically important difference for seven measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol 2008;35(4):635-42.
  3. Aviña-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: A meta-analysis of observational studies. Ann Rheum Dis 2012;71(9):1524-1529.
  4. Yurkovich M, Vostretsova K, Chen W, Aviña-Zubieta JA. Overall and cause-specific mortality in patients with systemic lupus erythematosus: A meta-analysis of observational studies. Arthritis Care Res 2014;66(4):608-16.
  5. Carruthers E, Choi HK, Sayre EC, Aviña-Zubieta JA. Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: A general population-based study. Ann Rheum Dis Sept 2014 doi:10.1136/annrheumdis-2014-205800. [Epub ahead of print].
  6. Galo JS, Mehat P, Rai SK, Avina-Zubieta JA, De Vera MA. What are the effects of medication adherence interventions in rheumatic diseases: A systematic review. Ann Rheum Dis. 2015 Feb 9. pii: annrheumdis-2014-206593. doi: 10.1136/annrheumdis-2014-206593. [Epub ahead of print].
  7. Amiri N, De Vera M, Choi HK, Sayre EC, Aviña-Zubieta JA. Increased risk of cardiovascular disease in giant cell arteritis: A general population-based study. Rheumatology (Oxford). 2015 Aug 5. pii: kev262. [Epub ahead of print].
  8. Barber C, Marshall D, Alvarez N, Mancini GBJ, Lacaille D, Keeling S, Aviña-Zubieta JA, Khodyakov D, Barnabe C, Faris P, Smith A, Noormohamed R, Hazlewood G, Martin L, Esdaile J. Development of cardiovascular quality indicators for rheumatoid arthritis: Results from an international expert panel using a novel online process. J Rheumatol. 2015 Sep;42(9):1548-55. doi: 10.3899/jrheum.141603. Epub 2015 Jul 15.
Awards & Recognition:

Scholar Award, Michael Smith Foundation for Health Research (MSFHR), 2014-2019

Scholar Award, BC Lupus Society, 2010-2015

Network Scholar Award, The Arthritis Society, 2010-2013

Current Grants listed as Principal Investigator or Co-Principal Investigator:

  • Effectiveness of online physical activity monitoring in inflammatory arthritis (OPAM-IA); A new model of care
  • The Arthritis Society, 2014-2017
  • The Impact of Arthritis Medications During Pregnancy on Maternal and Neonatal Health Outcomes
  • The Arthritis Society, 2014-2017
  • Risk of Cardiovascular Disease in Ankylosing Spondylitis
  • Arthritis Research Canada. 2015-2016

Current Grants listed as Co-Investigator

  • Supporting Patient care with Electronic Resource (SuPER): Efficacy of an online decision aid for patients considering biologic therapy for rheumatoid arthritis
  • Canadian Initiative for Outcomes in Rheumatology Care (CIORA), 2015-2017
  • Immune regulation by IL-6 in giant cell arteritis
  • The Vasculitis Foundation (USA), 2015-2016
  • Supporting Physical activity & Reducing sedentary Behavior in Arthritis (SuPRA)
  • Canadian Institutes of Health Research (CIHR), 2014-2016
  • Collaborative Care Model Involving eHealth to Improve Treatment Adherence and Health Outcomes of Patients with Gout
  • CIORA, 2015-2016
  • Preventing Complications from Inflammatory Skin, Joint and Bowel Conditions (PRECISION)
  • CIHR, 2014- 2019

Dr. Aviña currently mentors one PhD student, three master students, and six clinical trainees.